✦ LIBER ✦

P.28 Tolerance of the treatment with chemotherapy and/or radiotherapy in older patients with advanced lung cancer

✍ Scribed by Pilnik, N.; Mareca, O.; Bielochercovsky, R.; Carri, D.

Book ID: 122395209
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 73 KB
Volume: 64
Category: Article
ISSN: 1040-8428
DOI: 10.1016/S1040-8428(13)70201-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-839 A study of the tolerance to chemot

P-839 A study of the tolerance to chemotherapy and/or radiotherapy (Ch/Rxt) in older cancer patients with advanced lung cancer

✍ Pilnik, N.; Mareca, O.; Nasetta, M.; Ibero, M.; Carri, D. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 127 KB

P.29 Analysis of the tolerance to chemot

P.29 Analysis of the tolerance to chemotherapy/radiotherapy in older breast cancer patients

✍ Pilnik, N.; Mareca, O.; Ibero, M.; Nasetta, M.; Carri, D. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

84P VALUE OF CURATIVE TREATMENT CHEMOTHE

84P VALUE OF CURATIVE TREATMENT CHEMOTHERAPY AND RADIOTHERAPY VERSUS PALLIATIVE RADIOTHERAPY ALONE IN THE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER

✍ Dzhugashvili, M.; Fondevilla, A.; Bregu, L.; Mata, F.; Puchades, V.; Ramos, D.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Combination chemotherapy followed by sur

Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer

✍ F. KIRSTEN; K.H. ATKINSON; J. V. M. COPPLESON; P. M. ELLIOTT; D. GREEN; R. HOUGH 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB

8035 Tolerance of accelerated radiothera

8035 Tolerance of accelerated radiotherapy combined with chemotherapy in patients with advanced carcinoma of the uterine cervix

✍ Grzbiela, H.; Jedrus, S.; Raczek-Zwierzycka, K. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Combination chemotherapy with cisplatin

Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer

✍ F. Figoli; A. Veronesi; M. G. Trovo; D. Errante; M. Della Valentina; V. Zagonel; 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 447 KB

A total of 52 consecutive, previously untreated patients with small-cell lung cancer (SCLC) were scheduled to receive six cycles of a combination of etoposide (75 mg/m2 per day) and cisplatin (20 mg/m2 per day), each cycle given over 5 consecutive days. In all, 28 patients had extensive disease (ED)